-
07-05-2019, 06:06 PM
#351
Member
The quantity of her purchase offends me. That's not buying on market for her, that's a packet of gum at the dairy.
-
08-05-2019, 07:52 AM
#352
Yes but it is at least the transparency that the HC slingshots keep demanding while hiding behind pseudonyms, some multiples of the same person.
-
08-05-2019, 08:07 PM
#353
Seems Madam CEO has been ticking off the planned events from the late February strategy plan quite well and whats more in order.
UPCOMING NEWSFLOW – IN EXPECTED ORDER
Orphan drug filing--- check
Second QVC China event in March-- check
European import approval--- check
On track for 50 US stores by mid 2019
évolis® in Japan via e-commerce in mid 2019
Distribution partnerships --- Europe organised --- check
Awaiting China
-
09-05-2019, 10:48 AM
#354
Member
And with the marketing guru Kerry Yates suggesting that Evolis could be turning over 100 Million in the USA alone within 7 years the mind boggles as to what overall earnings will be when China, which is kicking in now, combined with Europe, Australia and the already profitable Japan are added to the mix.
-
09-05-2019, 07:21 PM
#355
Originally Posted by Tsuba
And with the marketing guru Kerry Yates suggesting that Evolis could be turning over 100 Million in the USA alone within 7 years the mind boggles as to what overall earnings will be when China, which is kicking in now, combined with Europe, Australia and the already profitable Japan are added to the mix.
And on top of that Kerry Yates of Colour Collective has taken up a role in the Cellmid management team.
Don't think she is there to play tiddly winks or whack a mole.
-
11-05-2019, 06:36 AM
#356
Member
As well as Kerry Yates and Colour Collective doing marketing for Evolis in the US we have Lisa Adams and her business which specialises in opening doors in retail distribution and brand strategy.They are working with Evolis and you can see some of the retail business’s they work with some of which are selling Evolis already: Soft Surroundings, Neiman Marcus and Bloomingdales.
https://www.thebeautymatchmakers.com
https://www.thebeautymatchmakers.com/our-retailers
https://www.thebeautymatchmakers.com/our-brands-1
Last edited by Tsuba; 11-05-2019 at 06:37 AM.
-
11-05-2019, 12:31 PM
#357
Originally Posted by Tsuba
As stated in the Strategy Plan of FEB 2019
http://www.cellmid.com.au/SiteMedia/...y%20Update.pdf
50 high end of the market stores in the States by mid year and 90 by year end should set the stage for a fair bit of growth
Literally and metaphorically.
-
14-05-2019, 10:47 AM
#358
See that Zoetis is still listed as a partner on the Cellmid company website.
Must be getting close to the end of their 4 year appraisal for MK use in companion animals.
-
14-05-2019, 01:06 PM
#359
Cellmid applied for Orphan Drug Status on CAB 102 for the treatment of a rare kidney disease in Mid March.
If the below is correct and in place still then we would be expecting an answer, yea or nay, by Mid June.
From the FDA Orphan Drug status on line'
SUMMARY OF KEY GOALS: FDA’S 90 IN 90 PLAN1. In 90 days, FDA will complete reviews of all orphan drug designation requests that are older than 120days (the backlog) while maintaining consistent, scientifically rigorous reviews; and2. After 90 days, 100 percent of all new orphan drug designation requests will receive a response by theagency within 90 days of receipt. FDA will adhere to this 90-day timeline going forward.
Views seem to be picking up on this thread, lets hope it translates into some new interest and an awakening to massive potential.
-
14-05-2019, 04:01 PM
#360
Member
With Europe locked and loaded with import permits and a major distributer plus QVC Germany probably on the cards I would not be surprised if QVC USA is not too far away.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks